Dr. Richard Stone

Dr. Richard Stone

Director of the Adult Acute Leukemia Program
Dana-Farber Cancer Institute

Dr. Richard Stone is Director of the Adult Acute Leukemia Program at DFCI.

Dr. Stone received his MD in 1981 from Harvard Medical School, his internal medicine residency training at Brigham and Women’s Hospital, and his hematology-oncology fellowship at DFCI. He has performed numerous laboratory and clinical studies on acute leukemia and related disorders, and frequently participates in grand rounds worldwide.

Treatment

Post-Remission Therapy For AML: Allogeneic Stem-Cell Transplant

Treatment

What Are The Phases of AML Treatment?

Treatment

Advancements in Treating Acute Myeloid Leukemia (AML)

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.